Source: http://www.google.com/patents/US6994094?dq=645576
Timestamp: 2017-06-28 18:15:43
Document Index: 763637747

Matched Legal Cases: ['art.\n18', 'art 100', 'art 100', 'art 100', 'art 100', 'art 100', 'art 100', 'art 100', 'art 100', 'art 100', 'art 100', 'art 100', 'art 100', 'art 100', 'art 100', 'art 100', 'art 100', 'art 100', 'art 100', 'art 100', 'art 100', 'art 100']

Patent US6994094 - Method and device for transseptal facilitation based on injury patterns - Google PatentsSearch Images Maps Play YouTube News Gmail Drive More »Sign inPatentsA method for performing a procedure at the fossa ovalis in the septal wall of the heart includes the steps of providing a sheath having a body wherein the body has a lumen extending therethrough and an open end at the distal end of the body. The body also has at least one electrode and a position sensor...http://www.google.com/patents/US6994094?utm_source=gb-gplus-sharePatent US6994094 - Method and device for transseptal facilitation based on injury patternsAdvanced Patent SearchTry the new Google Patents, with machine-classified Google Scholar results, and Japanese and South Korean patents.Publication numberUS6994094 B2Publication typeGrantApplication numberUS 10/425,165Publication dateFeb 7, 2006Filing dateApr 29, 2003Priority dateApr 29, 2003Fee statusPaidAlso published asCA2465617A1, EP1472974A1, US20040220462Publication number10425165, 425165, US 6994094 B2, US 6994094B2, US-B2-6994094, US6994094 B2, US6994094B2InventorsYitzhack SchwartzOriginal AssigneeBiosense, Inc.Export CitationBiBTeX, EndNote, RefManPatent Citations (12), Non-Patent Citations (2), Referenced by (118), Classifications (28), Legal Events (3) External Links: USPTO, USPTO Assignment, EspacenetMethod and device for transseptal facilitation based on injury patterns
US 6994094 B2Abstract
A method for performing a procedure at the fossa ovalis in the septal wall of the heart includes the steps of providing a sheath having a body wherein the body has a lumen extending therethrough and an open end at the distal end of the body. The body also has at least one electrode and a position sensor at the distal end of the body. The position sensor generates signals indicative of the location of the distal end of the body. The sheath is navigated to the septal wall using the position sensor and the fossa ovalis in the septal wall is identified using the at least one electrode of the sheath.
1. A method for performing a procedure at a fossa ovalis in a septal wall of a heart, the method comprising the steps of:
providing a sheath comprising a body, the body having a lumen extending therethrough and an open end at a distal end of the body, the body also having at least one electrode and a position sensor at the distal end of the body, the position sensor generating signals indicative of a location of the distal end of the body;
navigating the sheath to the septal wall using the position sensor;
reconstructing an electroanatomical map using the at least one electrode and the position sensor of the sheath;
identifying the fossa ovalis in the septal wall using the at least one electrode and the position sensor of the sheath; and
displaying the fossa ovalis as a tagged point on the map.
2. The method according to claim 1, further comprising identifying the fossa ovalis based on injury patterns detected using the at least one electrode.
3. The method according to claim 2, further comprising identifying the fossa ovalis by determing an injury pattern for an area on the septal wall that exhibits less of an injury pattern than injury patterns exhibited by other areas on the septal wall.
4. The method according to claim 3, further comprising detecting injury patterns using injury curves.
5. The method according to claim 4, further comprising detecting injury patterns with an electrocardiogram.
6. The method according to claim 5, further comprising displaying the injury patterns in the form of PQRST waves.
7. The method according to claim 2, further comprising identifying the fossa ovalis by finding an area on the septal wall that does not exhibit an injury pattern.
8. The method according to claim 1, further comprising determining the location coordinates of the tagged point using the position sensor.
9. The method according to claim 8, further comprising determining the location coordinates of the tagged point by identifying position coordinates of the point.
10. The method according to claim 9, further comprising identifying orientation coordinates for the tagged point.
11. The method according to claim 1, further comprising tagging the point at the fossa ovalis with a physical tag.
12. The method according to claim 11, further comprising tagging the point at the fossa ovalis using an active tag.
13. The method according to claim 11, further comprising tagging the point at the fossa ovalis using a passive tag.
14. The method according to claim 1, further comprising perforating the fossa ovalis.
15. The method according to claim 14, further comprising perforating the fossa ovalis by extending a penetrating device through the lumen and the distal end of the sheath.
16. The method according to claim 15, further comprising withdrawing the penetrating device from the sheath.
17. The method according to claim 16, further comprising extending a secondary device through the sheath and the fossa ovalis and into the left atrium of the heart.
18. The method according to claim 17, further comprising performing a diagnostic procedure in the left atrium with the secondary device.
19. The method according to claim 17, further comprising performing a therapeutic procedure in the left atrium with the secondary device.
The present invention relates to methods and devices for facilitating diagnostic and therapeutic procedures on tissue and more particularly, relates to methods and devices for performing a transseptal facilitation procedure.
In medical procedures involving a patient's heart 100, there are numerous diagnostic and therapeutic procedures that require transseptal left heart catheterization, i.e. catherization through left atrium 110 as shown in FIG. 1. The transseptal approach is an essential maneuver that provides access for both interventional cardiologists who perform antegrade mitral balloon valvuloplasty and for cardiac electrophysiologists who ablate left sided accessory pathways or perform transcatheter atrial-fibrillation therapeutic tactics.
In 15–25% of the normal healthy population, the interarterial septum (IAS) 105 has fossa ovalis or foramen ovale 107 that is patent, i.e. patent foramen ovale (PFO). The PFO is one of the three obligatory shunts in the normal fetal intrauterine blood circulation. The incidental presence of a PFO often enables a swift passage of a guide-wire across right atrium 115 and through septum 105. Pediatric cardiologists often use this route.
For procedures involving patient's already having a PFO (pre-existing hole at the fossa ovalis 107), generally a transesophageal ultrasonic probe (not shown) is inserted into the patient's mouth and placed in the esophagus. In most cases, the transesophageal ultrasonic probe is positioned approximately 30–35 cm from the mouth, i.e. in most cases positioned just above the patient's stomach.
Under transesophageal echocardiography (TEE), i.e. transesophageal ultrasonic guidance, a wire (not shown) is inserted into the right atrium 115 through an appropriate vessel such as the inferior vena cava 108 wherein the wire is guided through the fossa ovalis 107 by gently lifting the tissue flap away from the patent opening of the IAS 105 at the fossa ovalis 107. Once the wire is inserted through the fossa ovalis 107, the wire is guided to one of the pulmonary veins 116 for placement of the distal end of the wire in order to properly position and anchor the wire in the opening of the pulmonary vein 116. Accordingly, the pulmonary vein 116 has been proven to be a very reliable and steady anchoring point for the wire.
Once the wire is properly positioned in the fossa ovalis 107 and anchored in the pulmonary vein 116, a catheter sheath (“over-the-wire” type) is guided over the wire through the right atrium 115 and the fossa ovalis 107 and positioned within the left atrium 110, for instance, very close to the opening of the pulmonary vein 116.
Once the catheter sheath has been properly positioned, the wire is removed from the patient's heart 100 and other therapeutic and/or diagnostic devices are delivered through the catheter sheath. Some of these devices include implantable devices such as implantable pacemakers, electrodes, atrial septal defect (ASD) occlusion devices, etc. Accordingly, the implantable device is deliverable with typical delivery devices such as the Amplatzer® Delivery System, manufactured by AGA Medical Corporation of Golden Valley, Minn.
After placement of the catheter sheath, the implantable device is deployed from the catheter sheath within the fossa ovalis 107. Upon deployment, the implantable device is implanted into the IAS 105 thereby occluding the opening (PFO) at the fossa ovalis 107.
In all other patients, a transseptal perforation technique (anterograde approach) is necessary. However, this procedure can result in various life-threatening complications, some of which may occur because of insufficient antaomical landmarks in the heart 100. Thus, several methods have been proposed for guidance of transseptal catheterization, including transesophageal echocardiography (TEE) and intracardiac echo (ICE).
When conducting an anterograde approach with TEE, a transesophageal ultrasonic probe is positioned in the patient's esophagus as described above. Under transesophageal ultrasonic imaging guidance, an opening is made in the IAS 105 at the fossa ovalis 107 in order to facilitate and accommodate another therapeutic and/or diagnostic device. Thus, the opening is made with a penetrating device having a penetrating member such as a standard needle catheter, for example, the BRK™ Series Transseptal Needle manufactured by St. Jude Medical, Inc. of St. Paul, Minn. Accordingly, under transesophageal ultrasonic guidance, the needle catheter is initially placed in the right atrium 115 and positioned at the fossa ovalis 107. At this point, the tip of the needle of the needle catheter penetrates the fossa ovalis 107 and the catheter is inserted through the fossa ovalis 107 into the left atrium 110 through the newly created opening in the fossa ovalis 107 by the needle catheter. Once the opening in the fossa ovalis 107 is created, other therapeutic and/or diagnostic devices can be utilized.
Performing transseptal perforation safely and effectively during an anterograde approach procedure requires considerable expertise and only a minority of currently practicing physicians are performing this type of procedure on a regular, routine basis. In fact, many electrophysiologists are refraining from performing transseptal procedures because of lack of skill and unavailable guidance.
Up till now, there have been no devices or methods that can allow a physician to efficiently perform a transseptal facilitation or perforation procedure in an effective manner.
The present invention is directed toward methods and devices for performing diagnostic and/or therapeutic procedures on tissue and organs. Although the methods and their devices in accordance with the present invention can be used for any type of medical procedure (therapeutic and/or diagnostic procedure), the present invention is more specifically directed toward methods for performing a transseptal facilitation procedure on the septal wall of the heart. Particularly, the methods and devices in accordance with the present invention are useful for accurately identifying the location of the fossa ovalis and for facilitating the penetration of the septal wall at the fossa ovalis with a penetrating device (penetrating member) especially for those procedures involving an anterograde approach.
One embodiment of the present invention is a method for performing a procedure at the fossa ovalis in the septal wall of the heart wherein the method comprises the steps of providing a sheath comprising a body wherein the body has a lumen extending therethrough and an open end at a distal end of the body. The body also has at least one electrode at the distal end of the body for sensing parameters or characteristics of the tissue (septal wall of the heart in one example). One type of characteristic measured with the at least one electrode of the sheath body are injury patterns formed in or exhibited by the tissue. When identifying the fossa ovalis in the septal wall, the at least one electrode of the sheath is used to identify the fossa ovalis based on particular characteristics of the tissue of the septum and the fossa ovalis, for example, based on injury patterns exhibited by both the septum and the fossa ovalis.
Another aspect of the present invention is a device useful for performing a procedure on tissue, for instance, a transseptal facilitation procedure. One embodiment of the device in accordance with the present invention comprises a body having a lumen extending therethrough and an open end at a distal end of the body. At least one electrode is located at the distal end of the body for determining an injury pattern on the tissue.
Another embodiment of the present invention is directed toward a method for performing a procedure at the fossa ovalis in the septal wall of the heart wherein the method comprises the steps of providing a sheath comprising a body wherein the body has a lumen extending therethrough and an open end at a distal end of the body. The body also has at least one electrode and a position sensor at the distal end of the body. The position sensor generates signals indicative of the location of the distal end of the body. The sheath is navigated to the septal wall using the position sensor. And, the fossa ovalis in the septal wall is identified using the at least one electrode of the sheath.
The present invention also comprises a device for performing a procedure on tissue, for example, a transseptal facilitation procedure, wherein the device comprises a body having a lumen extending therethrough and an open end at a distal end of the body. The body also includes at least one electrode at the distal end for determining an injury pattern on the tissue. The body also includes a position sensor at the distal end for generating signals indicative of a location of the distal end of the body.
Another alternative embodiment in accordance with the present invention is directed toward a method for performing a procedure at the fossa ovalis in the septal wall of a heart wherein the method comprises the steps of identifying the septal wall of the heart and identifying the fossa ovalis in the septal wall. A point is identified on the fossa ovalis and the point is then tagged at the fossa ovalis. A sheath comprising a body wherein the body has a lumen extending therethrough and an open end at a distal end of the body is also used. The body also includes a position sensor at the distal end of the body wherein the position sensor generates signals indicative of a location of the distal end of the body. The sheath is navigated to the fossa ovalis at the tagged point using the position sensor. In one example, the tagged point is a location coordinate (having position and orientation coordinates) displayed on a map such as an electroanatomical map. In another example in accordance with the present invention, the tagged point is a physical tag, such as an active tag or a passive tag, which is placed at the point (at the identified location, i.e. position and/or orientation coordinates), at the fossa ovalis of the septal wall.
In all embodiments of the method in accordance with the present invention that involve a transseptal facilitation procedure, once the fossa ovalis is identified in the septal wall, a penetrating device (penetrating member) is used within the lumen of the sheath body and is extended out of the distal end of the sheath body such that the distal tip of the penetrating member punctures or penetrates the fossa ovalis creating an apperture in the fossa ovalis leading to the left atrium of the heart. Accordingly, access to the left atrium of the heart is provided.
FIG. 1 is a schematic view in cross-section of a heart;
FIG. 2 is a schematic view of a location system with a guiding sheath having a position sensor in accordance with the present invention;
FIG. 3 is a schematic view of the system of FIG. 2 in use on a patient in accordance with the present invention;
FIG. 4A is a partial perspective view of a distal end of a first alternative embodiment of the sheath of FIG. 2 in accordance with the present invention;
FIG. 4B is a partial view in cross-section of the sheath of FIG. 4A in accordance with the present invention;
FIG. 5 is a partial perspective view of a distal end of a second alternative embodiment of the sheath of FIG. 2;
FIG. 6A is a partial perspective view of a distal end of the sheath of FIG. 2 in accordance with the present invention;
FIG. 6B is a partial view in cross-section of the sheath of FIG. 6A in accordance with the present invention;
FIG. 7 is a partial perspective view of a distal end of a third alternative embodiment of the sheath of FIG. 2 in accordance with the present invention;
FIG. 8 is a partial perspective view of a distal end of a fourth alternative embodiment of the sheath of FIG. 2 in accordance with the present invention;
FIG. 9 is a partial perspective view of a distal end of a fifth alternative embodiment of the sheath of FIG. 2 in accordance with the present invention;
FIG. 10 is a partial perspective view of a distal end of a sixth alternative embodiment of the sheath of FIG. 2 in accordance with the present invention;
FIG. 11A is a schematic illustration of a guiding sheath having a position sensor in accordance with the present invention being used to identify the fossa ovalis in a method in accordance with the present invention;
FIG. 11B is a schematic illustration of the sheath having a position sensor and a penetrating device therein in accordance with the present invention being used to penetrate the fossa ovalis in the method of FIG. 11A in accordance with the present invention;
FIG. 12A is a schematic illustration of a guiding sheath having at least one electrode in accordance with the present invention being used for identifying the fossa ovalis in an alternative embodiment of the method in accordance with the present invention;
FIG. 12B is a schematic illustration of the sheath having at least one electrode and a penetrating device therein in accordance with the present invention being used to penetrate the fossa ovalis in the method of FIG. 12A in accordance with the present invention;
FIG. 13A is a schematic illustration of a guiding sheath having a position sensor and at least one electrode in accordance with the present invention being used to identify the fossa ovalis in another alternative embodiment of the method in accordance with the present invention;
FIG. 13B is a schematic illustration of the sheath having a position sensor and at least one electrode and a penetrating device therein in accordance with the present invention being used to penetrate the fossa ovalis in the method of FIG. 13A accordance with the present invention.
The present invention is directed toward methods and devices for performing diagnostic and/or therapeutic procedures on tissue to include, more particularly, procedures used to identify particular tissue, such as the fossa ovalis of the septal wall of the heart as part of a transseptal facilitation procedure.
As used herein, the term “tissue” is meant to describe all solid or semi-solid cellular matter in the body, such as muscle, nerve, connective tissue, vasculature and bone. Blood and other liquid matter, such as lymph, interstitial fluids or other fluids in the body, are excluded from the definition of“tissue” as defined herein.
One embodiment of the present invention, included within a diagnostic mapping and therapeutic delivery system, generally designated 118, is best shown in FIG. 2. The system comprises a flexible guiding sheath 120 for insertion into the human body (patient 90 shown in FIG. 3) by physician 151, and preferably, into a chamber, for example right atrium 115, of the human heart 100 (FIG. 1). The sheath 120 includes a sheath body 120 a having a distal end 22 and defining a lumen extending longitudinally through the body 120 a and terminating in an opening 122 a at distal tip 126. The lumen and opening 122 a of the sheath body 120 a serve as a working channel as will be described in greater detail later in this disclosure. The distal end 122 includes a distal tip electrode arrangement 124 (which is a recording electrode arrangement) at distal tip 126 for recording and measuring the electrical properties of the heart tissue such as recording injury patterns. Electrode arrangement 124 is also useful for sending electrical signals to the heart 100 for diagnostic purposes, e.g., for pace mapping, and/or for therapeutic purposes, e.g., for ablating defective cardiac tissue. While electrode 124 is designed to be in contact with tissue when performing its functions of receiving electrical signals from and transmitting electrical signals to the heart, it should be understood that electrode 124 is not always in contact with tissue. For example, electrode 124 may not be in contact with tissue as it is being advanced through the vasculature to the heart 100, or when it is being directed from one point to another point within the heart chamber such as right atrium 115.
Distal end 122 of sheath 120 may optionally include a second electrode 125 such as a reference electrode 125 for providing an internal reference measurement of impedance while the reference electrode 125 is in contact with blood but is not in contact with tissue or when both electrode 124 and second electrode 125 are in contact with tissue. Distal end 122 of sheath 120 further includes a location sensor (also referred to as a position sensor) 128 in some embodiments according to the present invention, that generates signals used to determine the position and orientation coordinates (location information) of the distal end 122 of sheath 120 within the patient's body 90. Location sensor 128 is preferably adjacent to distal tip 126 of sheath 120. There is preferably a fixed positional and orientational relationship of location sensor 128, tip 126 and electrode arrangement 124. Wires 123 carry the relevant signals to and from electrode 124, electrode 125 (if utilized) and location sensor 128.
The location sensor (position sensor) 128 is used to sense the instantaneous position of the distal end 122 and distal tip 126 of sheath 120. In a preferred embodiment of the invention, location sensor 128 is an AC magnetic field receiver, which senses an AC magnetic field generated by a plurality of magnetic field transmitters 127 which are also referred to as magnetic field generators or radiators which generate AC magnetic fields respectively to define a fixed frame of reference. Preferred location sensors 128 are further described in U.S. Pat. No. 5,391,199 and in PCT application PCT/US95/01103, published as WO96/05768 (U.S. patent application Ser. No. 08/793,371 filed May 14, 1997), the disclosures of which are incorporated herein by reference. The position and orientation coordinates of the distal end 122 and distal tip 126 of the sheath 120 are ascertained by determining the position and orientation of the location sensor 128 (through identifying the position and orientation coordinates thereof). In one embodiment of the invention, the location sensor 128 comprises one or more antennas 128 a (FIGS. 4B and 6B), for example one or more coils, or a plurality of coils 128 a which are irradiated by two or three radiators (transmitters) 127 which are outside the body surface of the patient 90. It should be understood that placement of the transmitters 127, as well as their size and shape, will vary according to the application of the invention. Preferably the transmitters 127 useful in a medical application comprise wound annular coils from about 2 to 20 cm in outer diameter (O.D.) and from about 0.5 to 2 cm thick, in a coplanar, triangular arrangement where the centers of the coils are from about 2 to 30 cm apart. Bar-shaped transmitters or even triangular or square-shaped coils could also be useful for such medical applications. Moreover, in instances where a prone patient 90 will be the subject of a procedure involving the instant invention, the transmitters 127 are preferably positioned in or below the surface upon which the patient 90 is resting (such as operating table 131), substantially directly below the portion of the patient's body 90 where a procedure is being performed. In other applications, the transmitters 127 may be fairly close to the skin of the patient 90. The transmitters 127 are driven by a radiator driver preferably in a manner described below, and the signals received by the receiving antennas (coils) 128 a of the location sensor 128 are amplified and processed, together with a representation of the signals used to drive transmitters 127, preferably in the manner described below, in signal processor 140, to provide a display or other indication of the position and orientation of the distal end 122 on monitor or display 142 of console 134. Transmitters 127 may be arranged in any convenient position and orientation, so long as they are fixed in respect to some reference frame, and so long as the transmitters 127 are non-overlapping, that is, there are no two transmitters 127 with the exact, identical location, i.e. position and orientation. When driven by radiator driver, the transmitters 127 generate a multiplicity of distinguishable AC magnetic fields that form the magnetic field sensed by receiving antennas (coils)128 a in the location sensor 128. The magnetic fields are distinguishable with regard to the frequency, phase, or both frequency and phase of the signals in the respective magnetic fields. Time multiplexing is also possible. Location sensor 128 may consist of a single coil 128 a, but preferably includes two or more and more preferably three sensor coils 128 a wound on either air cores or a core of material. In a preferred embodiment of the invention the coils 128 a have mutually orthogonal axes, one of which is conveniently aligned with the long longitudinal axis of the guiding sheath 120. Unlike prior art position sensors (used for other applications) which contain three coils that are concentrically located, or at least whose axes intercept, the coils 128 a of the preferred embodiment of the invention are closely spaced along the longitudinal axis of the sheath 120 to reduce the diameter of the location sensor 128 and thus make the sensor 128 suitable for incorporation into the sheath 120 (thereby defining a lumen 122 a as a working channel within guiding sheath 120). For most aspects of the present invention, quantitative measurement of the position and orientation (by determining position coordinates and orientation coordinates) of the sheath distal end 122 and distal tip 126 relative to a reference frame is necessary. This fixed frame of reference requires at least two non-overlapping transmitters 127 that generate at least two distinguishable AC magnetic fields; and location sensor 128, consisting of at least two non-parallel coils 128 a to measure the magnetic field flux resulting from the at least two distinguishable magnetic fields. The number of transmitters 127 times the number of coils 128 a is equal to or greater than the number of degrees of freedom of the desired quantitative measurement of the position and orientation of the coils 128 a of location sensor 128 relative to the reference frame established by the fixed or stationary transmitters 127, i.e. fixed to underside of table 131. Since, in a preferred embodiment of the invention it is preferred to determine six position and orientation coordinates (X, Y, Z directions and pitch, yaw and roll orientations) of the distal end 122 and distal tip 126 of the sheath 120, at least two coils 128 a are required in the location sensor 128. Preferably three coils 128 a are used to improve the accuracy and reliability of the position measurement. In some applications where fewer dimensions are required, only a single coil 128 a may be necessary for the location sensor 128 such that when used with transmitters 127, the system 118 determines five position and orientation coordinates (X, Y, Z directions and pitch and yaw orientations). Specific features and functions of a single coil system, (also referred to as a single axis system) is described in commonly assigned U.S. Pat. No. 6,484,118, which is incorporated herein in its entirety by reference. Leads (wires) 123 are used to carry signals detected by the sensor coils 128 a to signal processor 140, via the proximal end of the sheath 120, for processing to generate the required position and orientation information. Preferably, leads 123 are twisted pairs to reduce pick-up and may be further electrically shielded. In one embodiment of the invention, coils 128 a have an inner diameter of 0.5 mm and have 800 turns of 16 micrometer diameter to give an overall coil diameter of 1–1.2 mm. The effective capture area of the coil 128 a is preferably about 400 mm2. It will be understood that these dimensions may vary over a considerable range and are only representative of a preferred range of dimensions. In particular, the size of the coils 128 a can be as small as 0.3 mm (with some loss of sensitivity) and as large as 2 or more mm. The wire size of the coils 128 a can range from 10–31 micrometers and the number of turns between 300 and 2600, depending on the maximum allowable size and the wire diameter. The effective capture area should be made as large as feasible, consistent with the overally size requirements. While the preferred sensor coil shape 128 a is cylindrical, other shapes can also be used. For example a barrel shaped coil can have more turns than a cylindrical shaped coil for the same diameter of catheter. Also, square or other shaped coils may be useful depending on the geometry of the sheath 120. Location sensor 128 is preferably used to determine when sheath 120, is both in contact with the tissue of heart 100 (FIG. 1) and also to determine when the heart 100 is not in motion. During diastole, the heart 100 is relatively motionless for a short period of time (at most, a few hundred milliseconds). Alternatively to using a location sensor 128, the location of sheath 120 is determined using outside sensing or imaging means.
Guiding sheath 120 is either an over-the-wire type sheath that utilizes a guide wire (not shown) or may include a detachably connected handle 130, which includes controls 132 to steer the distal end 122 of the sheath 120 in a desired direction, such as deflecting the distal end 122, or to position and/or orient distal end 122 or distal tip 126 as desired.
The system 118, as shown in FIGS. 2 and 3, further comprises a console 134, which enables the user (physician 151) to observe and regulate the functions of sheath 120. Console 134 preferably includes a computer 136, keyboard 138, and display 142. Computer 136 contains control circuits to permit control and operation of the system 118 and to start and stop the collection of data from the sheath's electrode arrangement 124, second electrode or reference electrode 125 and from location sensor 128. Computer 136 further uses the electrical and or mechanical and location information acquired by electrodes 124 and 125 (when utilized) and location sensor 128 carried through wires 123 and processed by the circuits of signal processor 140 in the reconstruction and visualization of a map such as an electrical or electromechanical map of a portion of the heart 100 such as a chamber wall or interatrial septum (IAS) 105.
Signal processor 140 has circuits which typically receive, amplify, filter and digitize signals from sheath 120, including signals generated by location sensor 128, tip electrode 124 and second or reference electrode 125 (when utilized). Circuits of signal processor 140 further compute the position and orientation (position coordinates and orientation coordinates) of the sheath 120 as well as the electrical characteristics of the portions of heart 100 from the signals generated by location sensor 128 and tip electrode 124 respectively. Circuits of signal processor 140 also process body surface electrocardiogram signals. The digitized signals generated by the circuits of signal processor 140 are received and used by computer 136 to reconstruct and visualize an electrical or electromechanical map of portions of the heart 100 to include the septum 105.
In some embodiments of the invention, a return electrode 148 is used, for instance, by placement on an outer surface of the patient's body 90 and is preferably relatively large to provide low impedance between the return electrode 148 and the patient's body 90. For example, Electrosurgical Patient Plate model 1149F, supplied by 3M of St. Paul, Minn., which has an area of approximately 130 cm2, may be satisfactorily used as the return electrode 148 in the system and method of the invention.
FIGS. 6A and 6B depict the guiding sheath 120 used in conjunction with the location system 118 (FIG. 2). As shown in FIGS. 6A and 6B, the first electrode 124 is a distal tip electrode located at the distal end 122, particularly at the distal tip 126, of the body 120 a of the sheath 120. In this embodiment in accordance with the present invention, the distal tip electrode 124 can take the form of any desired shape or configuration, for example, a single elongated segment or a single electrode circumferentially arranged around the distal tip 126 of the body 120 a as shown. The location sensor 128 is located proximal to the tip electrode 124 and is located within the lumen 122 a of the sheath body 120 a. In this embodiment in accordance with the present invention, the location sensor 128 has a plurality of sensor coils 128 a, for instance, three coils 128 a (FIG. 6B). However, as mentioned above, the location sensor 128 can comprise any number of coils 128 a such as a single coil 128 a (as part of a single axis sensor), two coils 128 a or three coils, etc. The location sensor 128 is attached to the sheath body 120 a at a location proximal the tip electrode 124 in a manner that does not obstruct the lumen 122 a of the sheath body 120 a. Accordingly, the lumen 122 a defines a working channel that facilitates the introduction of secondary devices such as a penetrating device 150 having a penetrating member or any other desired diagnostic and/or therapeutic device configured in a manner, i.e. having a smaller diameter than the diameter defined by the lumen 122 a to facilitate diagnostic and/or therapeutic procedures using the guiding sheath 120, such as procedures as the novel transseptal facilitation procedures in accordance with the present invention described in greater detail later in this disclosure.
An alternative embodiment of the guiding sheath 120 is shown in FIG. 5 and consists of a single tip electrode 124 circumferentially arranged around the distal end 122 (at the distal tip 126) of the sheath body 120 a. In this emodiment, the guiding sheath 120 does not have a location sensor. Accordingly, the sheath 120 of FIG. 5 can be used in conjunction with other imaging and/or location modalities which can include fluoroscopic devices, and echography devices, ultrasound visualization devices such as trans-esophageal echocardiography and intracardiac echo devices or any other desired imaging modality. Particular methods of the present invention utilizing the guiding sheath 120 of FIG. 5 will be addressed later in this disclosure.
Moreover, although the guiding sheath 120 depicted in FIG. 5 is shown as a single tip electrode 124 circumferentially arranged around the distal end 122 of the body 120 a at the distal tip 126, the single electrode 124 can be any desired shape or configuration such as an elongated segment electrode, etc.
FIG. 7 shows another alternative embodiment for the guiding sheath 120 having distal end 122 with a split-tip electrode arrangement. In this embodiment in accordance with the present invention, the split-tip electrode arrangement comprises a hemi-circular arrangement having two electrode segments 124 a located on different halves of the distal end 122 at the distal tip 126 of the sheath body 120 a. An insulating portion 129 separates the electrode segments 124 a and serves as an insulating barrier positioned between each electrode segment 124 a. The two electrode segments 124 a can function either as two distinct and separate electrodes or the segments 124 a can function as a single electrode as desired. Each electrode segment 124 a forms a hemi-circular element at the distal end 126 thereby defining the distal end opening of the lumen 122 a of the sheath body 120 a. FIG. 8 depicts another alternative embodiment of the guiding sheath 120 in accordance with the present invention. The sheath 120 a of FIG. 8 is similar to the hemi-circular split-tip electrode arrangement shown in FIG. 7 with the addition of location sensor 128 located within the lumen 122 a of the sheath body 120 a and attached to inner surface of the body 120 a defining the lumen 122 a (working channel) wherein the location sensor 128 is located proximal to the hemi-circular split-tip electrode arrangement 124 a. The specific components, features and function of the location sensor 128 has been previously described above. Again, the location sensor 128 a is attached to the inner surface of the sheath body 120 a thereby defining the lumen 122 a (working channel) for facilitating and passing of secondary instruments therethrough as described above.
FIG. 9 shows another alternative embodiment of the guiding sheath 120 in accordance with the present invention having a semi-circular split-tip electrode arrangement comprising four electrode segments 124 b. Each electrode segment 124 b is partially and circumferentially arranged around the circumference of the distal tip 126 of the distal end 122 of the sheath body 120 a. Each electrode segment 124 b is separated from an adjacent electrode segment 124 b by insulating layer 129 which serves as an insulating barrier between adjacent electrode segments 124 b. The semi-circular split-tip electrode arrangement terminates in a distal opening therein contiguous with the lumen 122 a for facilitating secondary devices such as those described above for use in methods to be address later in this disclosure.
Additionally, the electrode segments 124 b can either function as four separate electrodes or four segments of a single electrode (a single distal tip electrode) as desired.
FIG. 10 shows another alternative embodiment of the guiding sheath 120 similar to the sheath depicted in FIG. 9 with the addition of the location sensor 128 located within the lumen 122 a of the sheath body 120 a and affixed to an inner surface of the sheath body 120 a and positioned at a location proximal to the electrode segments 124 b. Again, the location sensor 128 is affixed to the inner surface of the sheath body 120 a in a manner that defines the lumen 122 a as a working channel terminating in an opening at the distal tip 126 of the body 120 a in order to facilitate the introduction and withdrawal of secondary devices into and out of the sheath body 120 a. The alternative embodiments of the guiding sheath 120 depicted respectively in FIGS. 5, 6A, 6B, 7, 8, 9 and 10, all have at least one electrode which functions as a tip-electrode located at the distal tip 126 of the sheath body 120 a. All of the sheath embodiments in accordance with the present invention have a distal end 122 terminating in a distal tip 126 having a distal end opening contiguous with the lumen 122 a of the sheath body 120 a which serves as the working channel for the introduction and withdrawal of secondary devices. Additionally, the alternative distal tip electrode arrangements 124, 124 a and 124 b respectively, permit the distal end 122 and distal tip 126 of the guiding sheath 120 to be moved near or over tissue of interest. Particularly, the tip electrode arrangement 124, 124 a and 124 b respectively, are used to sense various characteristics or parameters of the tissue and generate signals indicative of these tissue characteristics or tissue parameters which are carried through wires 123 back to the signal processor 140 of the system 118 for measurement, analysis and depiction on the display 142. Although the distal tip electrode arrangements 124, 124 a and 124 b respectively used in conjunction with the guiding sheath 120 in accordance with the present invention can be used to detect any type of tissue characteristic or tissue parameter, these alternative distal tip electrode arrangements are particularly useful for sensing and determining injury patterns in tissue. This includes the detection of injury patterns particular to heart tissue to include the intra-arterial septum 105 and the fossa ovalis 107 of the heart 100 in accordance with novel methods of the present invention which will be addressed in greater detail below.
Additionally, the guiding sheath 120 depicted in FIGS. 5, 6A, 6B, 7, 8, 9 and 10 in accordance with the present invention can be used in conjunction with a guide wire, i.e. serve as a guiding sheath or an “over-the-wire” device through use of a guide wire. Alternatively, the guiding sheath 120 of the present invention depicted in FIGS. 5, 6A, 6B, 7, 8, 9 and 10 are not required to be used with a guide wire and can be used without such a device if desired, for example, the guiding sheath 120 can be used with the handle 130 as shown in FIG. 2.
Although the guiding sheath 120 depicted in FIGS. 5, 6A, 6B, 7, 8, 9 and 10 can be used in any desired tissue or organ sensing procedure, the guiding sheath 120 in accordance with the present invention is particularly useful for a transseptal facilitation procedure. For instance, FIGS. 12A and 12B show the guiding sheath 120 in accordance with the present invention used on the interatrial septum 105 in order to rapidly and efficiently identify the fossa ovalis 107 as well as an appropriate puncture site within the fossa ovalis 107.
In this procedure, the guiding sheath 120 is placed in the patient's body 90 (FIG. 3) and guided into the inferior vena cava 108 and into the right atrium 115. Again, the guiding sheath 120 can be used with or without a guiding wire (not shown). The guiding sheath 120 is guided to the interatrial septum 105 wherein the distal end 122 of the sheath body 120 a is used as a probe by placing the distal tip 126 against the tissue, i.e. the septum 105 such that the tip electrode arrangement, i.e. electrode segments 124 a contact the tissue of the septum 105. The distal tip electrode segments 124 a are used as recording electrodes that record particular characteristics of the septum 105, more particularly, an injury pattern. The injury pattern detected by the recording electrode segments 124 a is transmitted through wires 123 back to the signal processor 140 (FIGS. 2 and 3) for analysis.
Injury pattern analysis techniques are described in Bidoggia, et al., Transseptal Left Heart Catheterization: Usefulness of the Intracavitary Electrocardiogram in the Localization of the Fossa Ovalis, Catheterization and Cardiovascular Diagnosis 24(3):221–225(1991). When the recording electrode segments are 124 a placed against the muscular areas of the septum 105 or the free atrial wall, the recording electrode segments 124 a transmit signals that show a marked injury curve and are indicative of an injury pattern. These injury patterns are determined as part of an endoatrial electrocardiogram (EAE) wherein the EAE is depicted on the display 142 (FIG. 2) for analysis by the physician 151 (FIG. 3). The injury patterns depicted in electrocardiogram format are in the form of a PQRST complex that is analyzed in any desired combination of segments or waves. Additionally, when the distal electrode arrangement (recording electrode segments 124 a) are pressed into the endocardium at any muscular area of the septum 105 or atrial wall, the injury curve or injury pattern elicited and displayed becomes progressively severe as the pressure in increased against the tissue with the distal tip 126 of the sheath 120. In some instances, higher pressures exerted against this tissue with the distal tip 126 at the distal electrode arrangement results in a PQRST complex that is rather extraordinary or complex, i.e. in some instances it is depicted as a broad and bizarre monophasic injury curve.
Since the muscular areas of the septum 105 or free atrial wall display an injury pattern such as those outlined above, the recording electrode segments 124 a of the distal tip electrode arrangement are moved across the septum 105 by moving the electrode segments 124 a at distal tip 126 against the tissue of the septum 105 in any desired direction. While moving the distal tip 126 as electrode segments 124 a are in contact with the tissue of the septum 105, signals indicative of injury patterns are generated by the distal tip electrode arrangement (electrode segments 124 a) and transmitted through wires 123 to signal processor 140 to be recorded and displayed in real time, as a result of the recording electrode segments 124 a, which are displayed on the display 142. Since the fossa ovalis 107 has a tissue composition that is significantly thinner tissue (thin membrane when compared to the muscular areas of the septum 105 outside the fossa ovalis 107), the fossa ovalis 107 does not generate the same type of injury pattern exhibited by the muscular areas, i.e. the fossa ovalis 107 exhibits less of an injury pattern than the injury patterns exhibited by the muscular areas (areas outside the fossa ovalis 107) of the septum 105. Additionally, in many instances, the fossa ovalis 107 does not exhibit any injury pattern at all when recording and registering EAE patterns based on PQRST complex and particular segment analysis.
Accordingly, the distal tip electrode arrangement, i.e. in this embodiment recording electrode segments 124 a, at the distal tip 126 are navigated along the septum 105 until the recording electrode segments 124 a generate signals that exhibit very minor injury patterns (less of an injury pattern), when compared to the injury patterns exhibited by the muscular areas of the septum 105 previously recorded, or no injury patterns at all. Thus, when achieving this level of injury pattern (either slight or nonexistent injury pattern), the physician 151 (FIG. 3) readily knows that he or she has properly identified the fossa ovalis 107.
As shown in FIG. 12B, when the distal tip 126 of distal end 122 of the sheath body 120 a is located at the fossa ovalis 107, a secondary device such as a penetrating device 150 having a penetrating member is introduced into the lumen 122 a of the sheath body 120 a and extended through the opening (122 a) in the distal end of the sheath body 120 a at the distal tip 126 such that the penetrating member 150 is used to puncture and penetrate the fossa ovalis 107 in order to create an aperture (perforated point in the fossa ovalis 107) with access to the left atrium 110 of the heart 100. In a perforating procedure of the fossal ovalis 107 with the penetrating device 150, the penetrating device 150 is extended through the lumen 122 a (working channel) of the sheath body 120 a and out of the distal tip 126 at the distal end opening of the body 120 a. Once an aperture is made in the fossa ovalis 107 sufficient for accessing the left atrium 110, the penetrating device 150 is withdrawn from the lumen 122 a of the sheath body 120 a and another secondary device can be inserted into the body 120 through the lumen 122 a and extended out of the distal tip 126 of body 120 through the aperture (perforated point) in the fossa ovalis 107) and into the left atrium 110 of the heart 100. Acordingly, this further secondary device enables the physician 151 to perform a diagnostic procedure and/or a therapeutic procedure with this other secondary device in the left atrium 110.
Based on signal differences generated with the distal tip electrode arrangement, i.e. in this embodiment recording electrode segments 124 a, the physician 151 (FIG. 3) can determine the exact location of the fossa ovalis 107 by gradually moving the distal end 122 (at the distal tip 126) of the guiding sheath 120 along the septum 105 (with or without an imaging modality such as a fluoroscopy device) while the physician 151 reviews the recorded endocardial signals generated by the recording electrode segments 124 a. So long as the distal end 122 of the sheath 120 is relatively stable and one electrode segment 124 a records an injury pattern while the second or other electrode segment 124 a does not record a similar injury signal or pattern (in the form of a lesser or minor injury pattern than that injury pattern recorded by the first electrode segment 124 a), the physician 151 can assume that this second electrode segment 124 a is now in contact with or located within the fossa ovalis 107. By moving the distal tip 126 further in the direction of this second electrode segment 124 a, i.e. for instance through a slight downward adjustment of the distal end 122 position, both recording electrode segments 124 a will then be located within the fossa ovalis 107 such that a transseptal puncture and facilitation procedure such as that described above can be safely performed.
Additionally, it is also easy for the physician 151 to verify when the distal end 122 of the sheath 120 has passed into the left atrium 110, i.e. verification of the sheath 120 into the left atrium 110 after being passed through the newly created aperature in the fossa ovalis 107 of stepum 105. This verification occurs when there is a sudden change exhibited in the P-wave or P-segment recorded by the recording electrode segments 124 a after the distal end 122 of the sheath 120 has crossed over the septum 105 through the aperture made in the fossa ovalis 107 such that the distal end 122 of the sheath 120 resides within the left atrium 110 of the heart 100.
FIGS. 13A and 13B illustrate an alternative embodiment of the method in accordance with the present invention. The method of the present invention depicted in FIGS. 13A and 13B is also directed toward a procedure involving the septum 105 and the fossa ovalis 107 such as a transseptal facilitation procedure. This alternative embodiment of the method in accordance with the present invention is similar to the transseptal facilitation method depicted in FIGS. 12A and 12B and as described above, i.e. both the method embodiment of FIGS. 12A and 12B and the method embodiment of FIGS. 13A and 13B are substantially similar with the exception of the use of the location sensor 128 within the sheath body 120 a for the sheath 120 associated with the method embodiment of FIGS. 13A and 13B.
Accordingly, the method in accordance with the present invention depicted in FIGS. 13A and 13B is a navigated transseptal facilitation procedure utilizing the location sensor 128 located proximal of the distal tip electrode arrangement recording electrode segments 124 a for guided movement (electromagnetic field guidance or navigation) of the distal end 122 of the sheath 120 to the septum 105 of the heart 100 (FIG. 1) as well as guidance of the distal tip 126 and distal tip electrode arrangement, i.e. recording electrode segments 124 a against and across the tissue of the septum 105 and the fossa ovalis 107. Since the location sensor 128 generates signals for determining the location coordinates of the distal end 122 of the sheath 120, i.e. position coordinates and orientation coordinates, the sheath 120 can be guided and navigated to the heart 100 and within the heart 100 using only the location system 118 (FIGS. 2 and 3), i.e. without an imaging modality such as those mentioned previously. Thus, the method of navigated transseptal facilitation depicted in FIGS. 13A and 13B does not necessarily require an imaging modality such as fluoroscopy or any of the others mentioned above. Thus, the physician 151 (FIG. 3) can rely on the location information provided from the location sensor 128 in lieu of these imaging modalities. However, the sheath 120 having location sensor 128 as shown in FIGS. 13A and 13B can be utilized with any desired imaging modality such as fluoroscopy if the physician 151 so desires even through it is not a requirement in accordance with this embodiment of the method of the present invention.
When using the location sensor 128 on the distal end 122 of the sheath 120, the distal end 122 of the sheath 120 is navigated to the septal wall 105 using the location sensor 128. Additionally, as described in detail above (with respect to the method embodiment depicted in FIGS. 12A and 12B), the fossa ovalis 107 is identified in the septal wall 105 using the recording electrode segments 124 a and the injury pattern detection techniques described in detail above.
Moreover, as mentioned above, the fossa ovalis 107 is identified as an area on the septal wall 105 that exhibits an injury pattern that is less of an injury pattern or even no injury pattern at all when compared to the injury pattern exhibited by other areas on the septal wall 105, i.e. for instance, the muscular areas of the septal wall 105 such as those areas outside of the fossa ovalis 107.
The only differences between the method embodiment of FIGS. 13A and 13B when compared to the method embodiment of FIGS. 12A and 12B, is the addition of the location sensor 128 on the sheath 120 as well as the ability to forego use of an imaging modality such as fluoroscopy, which has been replaced with the electromagnetic navigation abilities afforded by the location sensor 128 and location system 118 (FIG. 2).
Furthermore, the transseptal facilitation method embodiments described in FIGS. 12A, 12B, 13A and 13B respectively can be conducted with any of the guiding sheath 120 embodiments of the present invention such as those depicted in FIGS. 5, 6A, 6B, 7, 8, 9 and 10. Thus, the tissue characteristic or injury pattern recording techniques described in these method embodiments is not limited to a distal tip electrode arrangement having two recording electrode segments 124 a, but also include distal tip recording electrode arrangements using a single distal tip electrode 124 such as a circumferentially arranged distal tip recording electrode 124 as shown in FIGS. 5, 6A and 6B respectively as well as the semi-circular distal tip recording electrode arrangement (four recording electrode segments 124 b) shown in FIGS. 9 and 10.
Although the sheath embodiment of FIG. 6A of the present invention is schematically illustrated in the method embodiment of FIGS. 12A and 12B and the sheath embodiment of FIG. 8 is schematically depicted in the method embodiment of FIGS. 13A and 13B, these alternative embodiments for the methods in accordance with the present invention, such as a transseptal facilitation procedure, are not limited to these particular sheath embodiments (i.e. the hemi-circular split tip recording electrode arrangement).
Another alternative embodiment of the sheath 120 in accordance with the present invention is illustrated in FIGS. 4A and 4B respectively. In this sheath embodiment in accordance with the present invention, the sheath 120 has a distal end 122 without any type of recording electrode arrangement. But rather, a location sensor 128 alone is located at the distal end 122. As described above, the location sensor 128 permits the sheath 120 to be navigated within the patient's body 90 to any desired location within the body 90 such as a particular tissue site. Since the particular configuration, features and function of the location sensor 128 and the location system 118 (FIG. 2) has been described in great detail above, novel methods utilizing the sheath embodiment of FIGS. 4A and 4B will now be addressed.
Accordingly, one method utilizing the sheath embodiment 120 depicted in FIGS. 4A and 4B is directed toward identifying a tissue site such as the fossa ovalis 107 on the septal wall 105 and is associated with a transseptal facilitation procedure. FIGS. 11A and 11B illustrate the sheath 120 embodiment of FIGS. 4A and 4B wherein an optimal puncture site 145 (also referred to as a tag site) is achieved through various available methods. This includes identifying both the septal wall of the heart, to include muscular areas on the septal wall 105 of the heart 100, as well as the thin, fibrous membrane-like areas of the fossa ovalis 107. These tissue identification methods include using such modalities as fluoroscopy imaging that can be utilized with electrode catheters positioned in the right atrial appendage of the right atrium 115, the His bundle region and coronary sinus which all can be used as anatomical landmarks, and geography, for instance right atrium 115 and angiography, or ultrasound visualization such as through transesophageal echocardiography (TEE) or intracardiac echocardiography (ICE). Upon identifying the fossa ovalis 107 in the septal wall 105, a point is tagged 145 (tagged puncture site) at the fossa ovalis 107. The tagged puncture site 145 can be a particular location coordinate (identified by position and orientation coordinates) determined by using the location sensor 128 or the tagged puncture site 145 can also be a physical tag such as an active tag or a passive tag placed in the tissue at this site. Examples of active tags and passive tags that can serve as the tagged puncture site 145 (tagged point 145) are described in detail in U.S. Pat. No. 6,332,089; U.S. patent application Ser. No. 09/265,715 filed Mar. 11, 1999; U.S. patent application Ser. No. 10/029,595 filed Dec. 21, 2001; and U.S. patent application Ser. No. 10/173,197 filed Jun. 17, 2002, the disclosures this patent and these applications are incorporated by reference herein.
The tagged puncture site or tagged point 145 in the fossa ovalis 107 can be identified using various imaging modalities or imaging devices include fluoroscopy imaging devices, angiography imaging devices, ultrasound imaging devices to include ultrasound imaging devices such as those based on transesophageal echocardiography or intracardiac echocargiography. Additionally, the tagged puncture site 145 or tagged point 145 can be identified by using anatomical landmarks such as those mentioned above.
Additionally, the tagged puncture site 145 or tagged point 145 in the fossa ovalis 107 can be identified using electroanatomical mapping using the location system 118 (FIG. 2) along with it's surface reconstruction software which has been described in detail above. When using the location system 118 in an electroanatomical mapping procedure, the tagged point 145 is displayed on an electrical anatomical map on the display 145 of the system 118 as shown in FIG. 2.
After identifying the tagged point 145, either through utilizing specific location coordinates determined by using the location system 118 or a physical tag (an active tag or a passive tag such as those mentioned above), the sheath 120 is guided and navigated to the tagged point 145 of the fossa ovalis 107 using the location sensor 128.
As best illustrated in FIG. 11B, a penetrating device 150 is inserted into the lumen 122 a of the body 120 a of the sheath 120 and is extended out of the distal end opening at the distal end 126 of the body 120 a such that the penetrating member 150 punctures the fossa ovalis 107 at the tagged point 145 (tagged puncture site 145) thereby creating an aperture in the fossa ovalis 107 leading to the chamber of the left atrium 110. Again, additional steps associated with transseptal facilitation procedures such as those steps described above include withdrawing the penetrating device 150 from the lumen 122 a of the sheath 120 and providing another type of secondary device (either a diagnostic or therapeutic device) shaped to fit within the lumen 122 a (working channel) of the sheath 120. Accordingly, these secondary devices can be used to perform either diagnostic procedures and/or therapeutic procedures in the left atrium 110 of the heart 100 after successful penetration of the fossa ovalis 107, i.e. at the tagged site 145.
Furthermore, all guiding sheath embodiments 120 shown in FIGS. 4A, 4B, 5, 6A, 6B, 7, 8, 9 and 10 respectively can be utilized either with a guide wire (not shown) or without a guide wire using the various guidance and navigation techniques previously described.
Patent CitationsCited PatentFiling datePublication dateApplicantTitleUS5391199Jul 20, 1993Feb 21, 1995Biosense, Inc.Apparatus and method for treating cardiac arrhythmiasUS5462545Jan 31, 1994Oct 31, 1995New England Medical Center Hospitals, Inc.Catheter electrodesUS6285898 *Jul 7, 1998Sep 4, 2001Biosense, Inc.Cardiac electromechanicsUS6332089Feb 14, 1997Dec 18, 2001Biosense, Inc.Medical procedures and apparatus using intrabody probesUS6484118Jul 20, 2000Nov 19, 2002Biosense, Inc.Electromagnetic position single axis systemUS6814733 *Jan 31, 2002Nov 9, 2004Biosense, Inc.Radio frequency pulmonary vein isolationUS20020017445Apr 15, 1998Feb 14, 2002Fujitsu LimitedPaper discriminating apparatusUS20040082860Dec 11, 2001Apr 29, 2004Michel HaissaguerreMicroelectrode catheter for mapping and ablationUS20040133113 *Aug 25, 2003Jul 8, 2004Krishnan Subramaniam C.Method and apparatus for locating the fossa ovalis and performing transseptal punctureWO1996005768A1Jan 24, 1995Feb 29, 1996Biosense, Inc.Medical diagnosis, treatment and imaging systemsWO1999039624A1Feb 5, 1998Aug 12, 1999Biosense Inc.Intracardiac drug deliveryWO2002071955A2Mar 14, 2002Sep 19, 2002Microheart, Inc.Method and apparatus for treatment of atrial fibrillation* Cited by examinerNon-Patent CitationsReference1Bidoggia et al. Transseptal Left Heart Catherization: Usefulness of the Intracavitary Electrocardiogram in the Localization of the Fossa Ovalis, Catherization and Cardiovascular Diagnosis 24(3) :221-225(1991).2European Patent Application No. EP04252449 dated Aug. 25, 2004.Referenced byCiting PatentFiling datePublication dateApplicantTitleUS7678132Jun 7, 2006Mar 16, 2010Ovalis, Inc.Systems and methods for treating septal defectsUS7686828Jun 7, 2006Mar 30, 2010Ovalis, Inc.Systems and methods for treating septal defectsUS7740640May 28, 2004Jun 22, 2010Ovalis, Inc.Clip apparatus for closing septal defects and methods of useUS7846179Sep 1, 2005Dec 7, 2010Ovalis, Inc.Suture-based systems and methods for treating septal defectsUS7860555Oct 25, 2005Dec 28, 2010Voyage Medical, Inc.Tissue visualization and manipulation systemUS7860556Nov 16, 2006Dec 28, 2010Voyage Medical, Inc.Tissue imaging and extraction systemsUS7918787Mar 16, 2007Apr 5, 2011Voyage Medical, Inc.Tissue visualization and manipulation systemsUS7930016Nov 16, 2006Apr 19, 2011Voyage Medical, Inc.Tissue closure systemUS7985254Jan 8, 2008Jul 26, 2011David TolkowskyEndobronchial fluid exhaler devices and methods for use thereofUS8019404Oct 5, 2007Sep 13, 2011The Cleveland Clinic FoundationApparatus and method for targeting a body tissueUS8050746Jul 10, 2007Nov 1, 2011Voyage Medical, Inc.Tissue visualization device and method variationsUS8070826Dec 11, 2003Dec 6, 2011Ovalis, Inc.Needle apparatus for closing septal defects and methods for using such apparatusUS8078266Feb 5, 2008Dec 13, 2011Voyage Medical, Inc.Flow reduction hood systemsUS8131350Dec 20, 2007Mar 6, 2012Voyage Medical, Inc.Stabilization of visualization cathetersUS8137333Jul 25, 2007Mar 20, 2012Voyage Medical, Inc.Delivery of biological compounds to ischemic and/or infarcted tissueUS8172757Jun 18, 2008May 8, 2012Sunnybrook Health Sciences CentreMethods and devices for image-guided manipulation or sensing or anatomic structuresUS8196580May 10, 2007Jun 12, 2012Yossi GrossImplantable respiration therapy deviceUS8221310Aug 30, 2007Jul 17, 2012Voyage Medical, Inc.Tissue visualization device and method variationsUS8235985Sep 11, 2008Aug 7, 2012Voyage Medical, Inc.Visualization and ablation system variationsUS8333012Oct 8, 2009Dec 18, 2012Voyage Medical, Inc.Method of forming electrode placement and connection systemsUS8369930Jun 16, 2010Feb 5, 2013MRI Interventions, Inc.MRI-guided devices and MRI-guided interventional systems that can track and generate dynamic visualizations of the devices in near real timeUS8396532Jun 16, 2010Mar 12, 2013MRI Interventions, Inc.MRI-guided devices and MRI-guided interventional systems that can track and generate dynamic visualizations of the devices in near real timeUS8417321Aug 24, 2011Apr 9, 2013Voyage Medical, IncFlow reduction hood systemsUS8419613Sep 13, 2011Apr 16, 2013Voyage Medical, Inc.Tissue visualization deviceUS8579936Jun 21, 2010Nov 12, 2013ProMed, Inc.Centering of delivery devices with respect to a septal defectUS8657805May 8, 2008Feb 25, 2014Intuitive Surgical Operations, Inc.Complex shape steerable tissue visualization and manipulation catheterUS8694071Feb 11, 2011Apr 8, 2014Intuitive Surgical Operations, Inc.Image stabilization techniques and methodsUS8694077Aug 10, 2011Apr 8, 2014The Cleveland Clinic FoundationApparatus and method for targeting a body tissueUS8709008May 9, 2008Apr 29, 2014Intuitive Surgical Operations, Inc.Visual electrode ablation systemsUS8747483Nov 16, 2012Jun 10, 2014ProMed, Inc.Needle apparatus for closing septal defects and methods for using such apparatusUS8758229Dec 20, 2007Jun 24, 2014Intuitive Surgical Operations, Inc.Axial visualization systemsUS8758401Sep 30, 2011Jun 24, 2014ProMed, Inc.Systems and methods for treating septal defectsUS8768433Dec 21, 2012Jul 1, 2014MRI Interventions, Inc.MRI-guided devices and MRI-guided interventional systems that can track and generate dynamic visualizations of the devices in near real timeUS8814845Feb 3, 2012Aug 26, 2014Intuitive Surgical Operations, Inc.Delivery of biological compounds to ischemic and/or infarcted tissueUS8821376Mar 12, 2008Sep 2, 2014David TolkowskyDevices and methods for performing medical procedures in tree-like luminal structuresUS8825133Jan 24, 2013Sep 2, 2014MRI Interventions, Inc.MRI-guided cathetersUS8858609Feb 6, 2009Oct 14, 2014Intuitive Surgical Operations, Inc.Stent delivery under direct visualizationUS8886288Jan 10, 2013Nov 11, 2014MRI Interventions, Inc.MRI-guided devices and MRI-guided interventional systems that can track and generate dynamic visualizations of the devices in near real timeUS8934962Aug 31, 2007Jan 13, 2015Intuitive Surgical Operations, Inc.Electrophysiology mapping and visualization systemUS9014851Mar 15, 2013Apr 21, 2015Hansen Medical, Inc.Systems and methods for tracking robotically controlled medical instrumentsUS9055906May 12, 2010Jun 16, 2015Intuitive Surgical Operations, Inc.In-vivo visualization systemsUS9057600Mar 13, 2014Jun 16, 2015Hansen Medical, Inc.Reducing incremental measurement sensor errorUS9072872Oct 29, 2010Jul 7, 2015Medtronic, Inc.Telescoping catheter delivery system for left heart endocardial device placementUS9101735Jul 7, 2009Aug 11, 2015Intuitive Surgical Operations, Inc.Catheter control systemsUS9138166Dec 7, 2011Sep 22, 2015Hansen Medical, Inc.Apparatus and methods for fiber integration and registrationUS9155452Apr 24, 2008Oct 13, 2015Intuitive Surgical Operations, Inc.Complex shape steerable tissue visualization and manipulation catheterUS9155587May 14, 2009Oct 13, 2015Intuitive Surgical Operations, Inc.Visual electrode ablation systemsUS9192287Jun 18, 2012Nov 24, 2015Intuitive Surgical Operations, Inc.Tissue visualization device and method variationsUS9226648Dec 20, 2007Jan 5, 2016Intuitive Surgical Operations, Inc.Off-axis visualization systemsUS9259290Jun 8, 2010Feb 16, 2016MRI Interventions, Inc.MRI-guided surgical systems with proximity alertsUS9271663Mar 15, 2013Mar 1, 2016Hansen Medical, Inc.Flexible instrument localization from both remote and elongation sensorsUS9289578May 14, 2015Mar 22, 2016Hansen Medical, Inc.Reducing incremental measurement sensor errorUS9332893Aug 5, 2014May 10, 2016Intuitive Surgical Operations, Inc.Delivery of biological compounds to ischemic and/or infarcted tissueUS9439735Jun 8, 2010Sep 13, 2016MRI Interventions, Inc.MRI-guided interventional systems that can track and generate dynamic visualizations of flexible intrabody devices in near real timeUS9463268Sep 7, 2011Oct 11, 2016Paul A. SpenceCannula systems and methodsUS9468364Nov 13, 2009Oct 18, 2016Intuitive Surgical Operations, Inc.Intravascular catheter with hood and image processing systemsUS9492623Oct 22, 2013Nov 15, 2016The Cleveland Clinic FoundationApparatus and method for targeting a body tissueUS9498584Oct 22, 2013Nov 22, 2016The Cleveland Clinic FoundationApparatus and method for targeting a body tissueUS9498585Oct 22, 2013Nov 22, 2016The Cleveland Clinic FoundationApparatus and method for targeting a body tissueUS9510732Jul 8, 2009Dec 6, 2016Intuitive Surgical Operations, Inc.Methods and apparatus for efficient purgingUS9526401Jan 16, 2013Dec 27, 2016Intuitive Surgical Operations, Inc.Flow reduction hood systemsUS9585991Oct 16, 2013Mar 7, 2017Heartware, Inc.Devices, systems, and methods for facilitating flow from the heart to a blood pumpUS20040127917 *Dec 11, 2003Jul 1, 2004Ginn Richard S.Needle apparatus for closing septal defects and methods for using such apparatusUS20040249398 *May 28, 2004Dec 9, 2004Ginn Richard S.Clip apparatus for closing septal defects and methods of useUS20060052821 *Jul 5, 2005Mar 9, 2006Ovalis, Inc.Systems and methods for treating septal defectsUS20060212047 *Jun 7, 2006Sep 21, 2006Ryan AbbottSystems and Methods for Treating Septal DefectsUS20060212071 *Jun 7, 2006Sep 21, 2006Ginn Richard SSystems and Methods for Closing Internal Tissue DefectsUS20060217763 *Jun 7, 2006Sep 28, 2006Ryan AbbottSystems and Methods for Treating Septal DefectsUS20060217764 *Jun 7, 2006Sep 28, 2006Ryan AbbottSystems and Methods for Treating Septal DefectsUS20070049970 *Sep 1, 2005Mar 1, 2007Ovalis Inc.Suture-based systems and methods for treating septal defectsUS20070073315 *Nov 9, 2006Mar 29, 2007Richard GinnSystems And Methods For Closing Internal Tissue DefectsUS20070073337 *Nov 9, 2006Mar 29, 2007Ryan AbbottClip-Based Systems And Methods For Treating Septal DefectsUS20070112358 *Jun 29, 2006May 17, 2007Ryan AbbottSystems and Methods for Treating Septal DefectsUS20070129756 *Jun 7, 2006Jun 7, 2007Ryan AbbottClip-Based Systems and Methods for Treating Septal DefectsUS20070167828 *Nov 16, 2006Jul 19, 2007Vahid SaadatTissue imaging system variationsUS20070293724 *Jun 14, 2007Dec 20, 2007Voyage Medical, Inc.Visualization apparatus for transseptal accessUS20080015445 *Jul 10, 2007Jan 17, 2008Voyage Medical, Inc.Tissue visualization device and method variationsUS20080015569 *Jul 10, 2007Jan 17, 2008Voyage Medical, Inc.Methods and apparatus for treatment of atrial fibrillationUS20080015633 *May 4, 2007Jan 17, 2008Ryan AbbottSystems and Methods for Treating Septal DefectsUS20080058591 *Aug 30, 2007Mar 6, 2008Voyage Medical, Inc.Tissue visualization device and method variationsUS20080058650 *Aug 30, 2007Mar 6, 2008Voyage Medical, Inc.Coronary sinus cannulationUS20080140073 *Feb 15, 2008Jun 12, 2008Yitzhack SchwartzTransseptal facilitation using sheath with electrode arrangementUS20080183036 *Dec 18, 2007Jul 31, 2008Voyage Medical, Inc.Systems and methods for unobstructed visualization and ablationUS20080249397 *Oct 5, 2007Oct 9, 2008The Cleveland Clinic FoundationApparatus and method for targeting a body tissueUS20080275300 *Apr 24, 2008Nov 6, 2008Voyage Medical, Inc.Complex shape steerable tissue visualization and manipulation catheterUS20080281293 *May 8, 2008Nov 13, 2008Voyage Medical, Inc.Complex shape steerable tissue visualization and manipulation catheterUS20090030276 *Jul 25, 2008Jan 29, 2009Voyage Medical, Inc.Tissue visualization catheter with imaging systems integrationUS20090030412 *May 9, 2008Jan 29, 2009Willis N ParkerVisual electrode ablation systemsUS20090054803 *Aug 31, 2007Feb 26, 2009Vahid SaadatElectrophysiology mapping and visualization systemUS20090054912 *Jul 18, 2008Feb 26, 2009Heanue Taylor ASystems and Methods for Treating Septal DefectsUS20090062790 *Aug 29, 2008Mar 5, 2009Voyage Medical, Inc.Direct visualization bipolar ablation systemsUS20090076498 *Sep 11, 2008Mar 19, 2009Voyage Medical, Inc.Visualization and ablation system variationsUS20090088648 *Jun 18, 2008Apr 2, 2009Ronen JaffeMethods and devices for image-guided manipulation or sensing or anatomic structuresUS20090088796 *Oct 29, 2008Apr 2, 2009Ryan AbbottSystems and Methods for Treating Septal DefectsUS20090107511 *May 10, 2007Apr 30, 2009Yossi GrossImplantable respiration therapy deviceUS20090125022 *Nov 10, 2008May 14, 2009Voyage Medical, Inc.Tissue visualization and ablation systemsUS20090143640 *Nov 25, 2008Jun 4, 2009Voyage Medical, Inc.Combination imaging and treatment assembliesUS20090203962 *Feb 6, 2009Aug 13, 2009Voyage Medical, Inc.Stent delivery under direct visualizationUS20090221871 *May 12, 2009Sep 3, 2009Voyage Medical, Inc.Precision control systems for tissue visualization and manipulation assembliesUS20090275842 *Dec 20, 2007Nov 5, 2009Vahid SaadatStabilization of visualization cathetersUS20090299363 *Dec 20, 2007Dec 3, 2009Vahid SaadatOff-axis visualization systemsUS20090318956 *May 20, 2009Dec 24, 2009Belef W MartinWire-Like And Other Devices For Treating Septal Defects And Systems And Methods For Delivering The SameUS20090326572 *Jun 11, 2009Dec 31, 2009Ruey-Feng PehApparatus and methods for rapid tissue crossingUS20100004506 *Sep 11, 2009Jan 7, 2010Voyage Medical, Inc.Tissue visualization and manipulation systemsUS20100004633 *Jul 7, 2009Jan 7, 2010Voyage Medical, Inc.Catheter control systemsUS20100041949 *Mar 12, 2008Feb 18, 2010David TolkowskyDevices and methods for performing medical procedures in tree-like luminal structuresUS20100130836 *Nov 13, 2009May 27, 2010Voyage Medical, Inc.Image processing systemsUS20100234879 *Mar 16, 2010Sep 16, 2010Ryan AbbottSystems and Methods for Treating Septal DefectsUS20100256629 *Apr 6, 2010Oct 7, 2010Voyage Medical, Inc.Methods and devices for treatment of the ostiumUS20100256670 *May 5, 2010Oct 7, 2010Ginn Richard SSystems And Methods For Closing Internal Tissue DefectsUS20100262183 *Nov 5, 2008Oct 14, 2010Ovalis Inc.Systems devices and methods for achieving transverse orientation in the treatment of septal defectsUS20100292558 *May 12, 2010Nov 18, 2010Voyage Medical, Inc.In-vivo visualization systemsUS20100312094 *Jun 8, 2010Dec 9, 2010Michael GuttmanMri-guided surgical systems with preset scan planesUS20100312096 *Jun 8, 2010Dec 9, 2010Michael GuttmanMri-guided interventional systems that can track and generate dynamic visualizations of flexible intrabody devices in near real timeUS20100317962 *Jun 16, 2010Dec 16, 2010Jenkins Kimble LMRI-Guided Devices and MRI-Guided Interventional Systems that can Track and Generate Dynamic Visualizations of the Devices in near Real TimeUS20110060227 *Nov 16, 2010Mar 10, 2011Voyage Medical, Inc.Tissue visualization and manipulation systemUS20110060298 *Nov 16, 2010Mar 10, 2011Voyage Medical, Inc.Tissue imaging and extraction systemsUS20110093007 *Jun 21, 2010Apr 21, 2011Ovalis, Inc.Systems and methods for treating septal defects* Cited by examinerClassifications U.S. Classification128/898, 600/374, 128/899International ClassificationA61B5/04, A61B5/06, A61B5/042, A61B17/34, A61B18/14, A61B19/00, A61B17/00, A61B1/313Cooperative ClassificationA61B2017/00243, A61B2017/00053, A61B5/0422, A61B2017/00292, A61B34/20, A61B2018/1467, A61B2018/00839, A61B18/1492, A61B2018/00351, A61B1/3137, A61B5/064, A61B2034/2051, A61B5/06European ClassificationA61B5/06C3, A61B19/52H12, A61B5/042D, A61B18/14VLegal EventsDateCodeEventDescriptionSep 15, 2003ASAssignmentOwner name: BIOSENSE, INC., NEW JERSEYFree format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SCHWARTZ, YITZHACK;REEL/FRAME:014487/0269Effective date: 20030808Jul 8, 2009FPAYFee paymentYear of fee payment: 4Mar 13, 2013FPAYFee paymentYear of fee payment: 8RotateOriginal ImageGoogle Home - Sitemap - USPTO Bulk Downloads - Privacy Policy - Terms of Service - About Google Patents - Send FeedbackData provided by IFI CLAIMS Patent Services